Gregory Norden is Director of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 2,826 shares of PRAX, which is worth approximately $210,537. The most recent transaction as insider was on May 12, 2021, when has been sold 2,826 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.83K
0% 3M change
0% 12M change
Total Value Held $210,537

Gregory Norden Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2021
BUY
Other acquisition or disposition
-
2,826 Added 50.0%
2,826 Common Stock

Also insider at

NSTG
NanoString Technologies Inc Healthcare
ZTS
Zoetis Inc. Healthcare
RPRX
Royalty Pharma plc Healthcare
GN

Gregory Norden

Director
Parsippany, NJ

Track Institutional and Insider Activities on PRAX

Follow Praxis Precision Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Insider Trading

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

News

Receive news related to Praxis Precision Medicines, Inc.

Track Activities on PRAX